NEW YORK (GenomeWeb News) — Gene Logic has promoted Thomas Barnes to senior vice president of discovery, a position that will put him in charge of drug repositioning, the company said this week.
 
Barnes will take over the position from Louis Tartaglia, who is resigning from the job to become a partner in a venture capital firm. 
 
Barnes formerly was co-founder of drug repositioning at Millennium Pharmaceuticals, which is now owned by Gene Logic.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.